Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Ocular Surface Disease > Symptomatic MGD shows distinct age-related clinical patterns
  • Ocular Surface Disease

Symptomatic MGD shows distinct age-related clinical patterns

Ophthalmology 360

Key Takeaways

  1. Younger patients with symptomatic MGD were more likely to have incomplete blinking, lower lipid layer thickness, and greater gland distortion.
  2. Older age was associated with increased meibomian gland plugging, lid margin abnormalities, gland shortening, and gland dropout.
  3. Lipid layer thickness increased with age, despite more structural gland changes in older patients.

Symptomatic meibomian gland dysfunction (MGD) presents differently across age groups, with younger patients showing signs linked to reduced lipid layer thickness (LLT) and altered blinking patterns, while older patients exhibit more pronounced structural gland and lid margin changes, according to a study.

In the cross-sectional study of 100 symptomatic Asian patients, researchers found that younger age was associated with more incomplete blinking, lower LLT, and greater meibomian gland distortion. In contrast, increasing age was linked to higher LLT, greater meibomian gland plugging, anterior displacement of the mucocutaneous junction, telangiectasia, larger gland dropout areas, and increased gland shortening and dropout.

Younger age and the absence of meibomian gland plugging were identified as independent predictors of reduced LLT. A decade-based analysis also demonstrated a significant increase in LLT with advancing age.

The researchers noted that the age-associated increase in LLT likely reflects obstructive and compensatory mechanisms rather than improved tear film function.

Reference

Chang JY, Cheng CA, Hwang DK, Fan NW. Age Spectrum of Meibomian Gland Dysfunction: A Cross-Sectional Study. Cornea. 2026;doi: 10.1097/ICO.0000000000004206. Epub ahead of print. PMID: 42333528.

Share

Related Content

  • Ocular Surface Disease

Scleral lenses improve vision and symptoms across ocular surface diseases

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Neurotrophic Keratitis

Novel anterior keratoplasty approach supports healing in refractory ocular surface disease

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane shows short- and long-term improvements in ocular surface disease

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon